2016
Exploring Explanations for the Female-Male Earnings Difference Among Registered Nurses in the United States.
Muench U, Busch SH, Sindelar J, Buerhaus PI. Exploring Explanations for the Female-Male Earnings Difference Among Registered Nurses in the United States. Nursing Economics 2016, 34: 214-23. PMID: 29975036.Peer-Reviewed Original Research
2015
Salary Differences Between Male and Female Registered Nurses in the United States
Muench U, Sindelar J, Busch SH, Buerhaus PI. Salary Differences Between Male and Female Registered Nurses in the United States. JAMA 2015, 313: 1265-1267. PMID: 25803350, DOI: 10.1001/jama.2015.1487.Peer-Reviewed Original Research
2012
Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample
Young-Wolff KC, Hyland AJ, Desai R, Sindelar J, Pilver CE, McKee SA. Smoke-free policies in drinking venues predict transitions in alcohol use disorders in a longitudinal U.S. sample. Drug And Alcohol Dependence 2012, 128: 214-221. PMID: 22999418, PMCID: PMC4052952, DOI: 10.1016/j.drugalcdep.2012.08.028.Peer-Reviewed Original ResearchConceptsAlcohol use disorderSmoke-free legislationSmoke-free policiesAUD remissionUse disordersLikelihood of AUDWave IIndoor public venuesLongitudinal U.S. sampleTobacco-related diseasesYounger age groupsNational Epidemiological SurveySmoke-free barsPublic health benefitsAUD onsetHigh comorbidityProtective effectCurrent drinkersTobacco useEpidemiological surveyAge groupsLogistic regressionRelated conditionsHeavy drinkingLower likelihood
2011
UNDERSTANDING HETEROGENEITY IN PRICE ELASTICITIES IN THE DEMAND FOR ALCOHOL FOR OLDER INDIVIDUALS
Ayyagari P, Deb P, Fletcher J, Gallo W, Sindelar JL. UNDERSTANDING HETEROGENEITY IN PRICE ELASTICITIES IN THE DEMAND FOR ALCOHOL FOR OLDER INDIVIDUALS. Health Economics 2011, 22: 89-105. PMID: 22162113, PMCID: PMC3641566, DOI: 10.1002/hec.1817.Peer-Reviewed Original ResearchConceptsPrice elasticityRetirement Study dataDeadweight lossHigher taxPrice responsivenessNegative externalitiesUnobserved heterogeneityPolicy implicationsFinancial resourcesExternalitiesPricesFinite mixture modelDisadvantaged groupsElasticityLatent groupsDemandTaxGreater responsivenessOlder IndividualsStudy dataHeterogeneityImplicationsResources
2008
Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients
Jones ES, Moore BA, Sindelar JL, O’Connor P, Schottenfeld RS, Fiellin DA. Cost analysis of clinic and office-based treatment of opioid dependence: Results with methadone and buprenorphine in clinically stable patients. Drug And Alcohol Dependence 2008, 99: 132-140. PMID: 18804923, PMCID: PMC2646001, DOI: 10.1016/j.drugalcdep.2008.07.013.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBuprenorphineCohort StudiesCost of IllnessCosts and Cost AnalysisData Interpretation, StatisticalFemaleHealth PersonnelHumansMaleMethadoneMiddle AgedNarcoticsOpioid-Related DisordersPhysicians' OfficesSocioeconomic FactorsSubstance Abuse DetectionSubstance Abuse Treatment CentersTreatment OutcomeYoung AdultConceptsOffice-based treatmentOpioid dependencePatient costsClinical contactMonthly medication costsOffice-based buprenorphineOffice-based methadoneMonths of treatmentAnalysis of treatmentTotal monthly costsChi-square testMonths of maintenanceStable patientsMedication costsPatientsMethadoneMonthly costBuprenorphineTreatmentMonthsStatistical comparisonCost estimatesClinic
2007
Willingness to pay for drug rehabilitation: Implications for cost recovery
Bishai D, Sindelar J, Ricketts EP, Huettner S, Cornelius L, Lloyd JJ, Havens JR, Latkin CA, Strathdee SA. Willingness to pay for drug rehabilitation: Implications for cost recovery. Journal Of Health Economics 2007, 27: 959-972. PMID: 18207264, PMCID: PMC2601723, DOI: 10.1016/j.jhealeco.2007.11.007.Peer-Reviewed Original ResearchCost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
Rosenheck RA, Leslie DL, Sindelar JL, Miller EA, Tariot PN, Dagerman KS, Davis SM, Lebowitz BD, Rabins P, Hsiao JK, Lieberman JA, Schneider LS. Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease. JAMA Psychiatry 2007, 64: 1259-1268. PMID: 17984395, DOI: 10.1001/archpsyc.64.11.1259.Peer-Reviewed Original ResearchConceptsCost-benefit analysisSecond-generation antipsychoticsGreatest net health benefitNet benefit analysisNet health benefitWholesale priceHealth Utilities Index Mark 3Economic perspectiveAlzheimer's diseaseBenefit approachHealth care costsTotal health costsHealth costsQALYsCare costsMeasures of effectivenessPlacebo-controlled trialLower health care costsHealth service useTotal health careMeasures of functionCostTreatment of psychosisQuality of lifeSensitivity analysisThe cost‐effectiveness of four treatments for marijuana dependence
Olmstead TA, Sindelar JL, Easton CJ, Carroll KM. The cost‐effectiveness of four treatments for marijuana dependence. Addiction 2007, 102: 1443-1453. PMID: 17645430, PMCID: PMC2398724, DOI: 10.1111/j.1360-0443.2007.01909.x.Peer-Reviewed Original ResearchConceptsMET/CBTDrug counselingContingency managementPatient outcomesYoung adultsEffective treatmentMarijuana dependenceAcceptability curvesIncremental cost-effectiveness ratioRandomized clinical trialsCost of therapyPatient outcome measuresCost-effective dependsCost-effectiveness ratioSubstance abuse clinicsCost-effective treatmentCM procedureClinical trialsOutcome measuresUrine specimenUrine specimensAdditional weeksAdditional studiesMarijuana abstinenceLonger durationSmoking Status as a Clinical Indicator for Alcohol Misuse in US Adults
McKee SA, Falba T, O’Malley S, Sindelar J, O’Connor P. Smoking Status as a Clinical Indicator for Alcohol Misuse in US Adults. JAMA Internal Medicine 2007, 167: 716-721. PMID: 17420431, PMCID: PMC2869385, DOI: 10.1001/archinte.167.7.716.Peer-Reviewed Original ResearchConceptsClinical care guidelinesSmoking statusPositive predictive valueClinical indicatorsAlcohol misuseUS adultsPositive likelihood ratioCurrent smokingCare guidelinesOdds ratioAlcohol diagnosisAssociated Disabilities Interview Schedule-IVPredictive valueHazardous drinkingPrimary care settingAlcohol-related diagnosesConfidence intervalsAlcohol use disorderNational Epidemiological SurveyAlcohol use diagnosisHazardous drinking behaviorLikelihood ratioOccasional smokersPrimary careDaily smokersDirect Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs
McCarty D, Fuller BE, Arfken C, Miller M, Nunes EV, Edmundson E, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW. Direct Care Workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, Opinions, and Beliefs. Psychiatric Services 2007, 58: 181-190. PMID: 17287373, PMCID: PMC2861362, DOI: 10.1176/ps.2007.58.2.181.Peer-Reviewed Original ResearchAdultAge FactorsAlcoholismAttitude of Health PersonnelBehavior TherapyClinical Trials as TopicCognitive Behavioral TherapyCultureData CollectionDiffusion of InnovationEducational StatusEthnicityEvidence-Based MedicineFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPatient Care TeamProfessional CompetenceProfessional-Patient RelationsPsychotropic DrugsSex FactorsSocioeconomic FactorsSubstance Abuse Treatment CentersSubstance-Related DisordersUnited StatesWhat do we get for our money? Cost‐effectiveness of adding contingency management
Sindelar J, Elbel B, Petry NM. What do we get for our money? Cost‐effectiveness of adding contingency management. Addiction 2007, 102: 309-316. PMID: 17222286, DOI: 10.1111/j.1360-0443.2006.01689.x.Peer-Reviewed Original Research
2006
Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J. Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia. American Journal Of Psychiatry 2006, 163: 2080-2089. PMID: 17151158, DOI: 10.1176/ajp.2006.163.12.2080.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntipsychotic AgentsChronic DiseaseCost-Benefit AnalysisDrug CostsFollow-Up StudiesHealth Care CostsHumansLongitudinal StudiesMiddle AgedPatient DropoutsPerphenazinePsychiatric Status Rating ScalesQuality-Adjusted Life YearsResearch DesignSchizophreniaSchizophrenic PsychologyTreatment OutcomeEffectiveness of Switching Antipsychotic Medications
Essock SM, Covell NH, Davis SM, Stroup TS, Rosenheck RA, Lieberman JA. Effectiveness of Switching Antipsychotic Medications. American Journal Of Psychiatry 2006, 163: 2090-2095. PMID: 17151159, DOI: 10.1176/ajp.2006.163.12.2090.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntipsychotic AgentsBenzodiazepinesCross-Over StudiesDibenzothiazepinesDose-Response Relationship, DrugDouble-Blind MethodDrug Administration ScheduleHumansMiddle AgedOlanzapinePatient DropoutsPsychotherapyQuetiapine FumarateResearch DesignRisperidoneSchizophreniaSchizophrenic PsychologySelection BiasSurvival AnalysisTreatment OutcomeConceptsMedication changesDifferent antipsychoticsCause treatment discontinuationCurrent medication regimensClinical Antipsychotic TrialsPhase 1 analysisPhase 1 findingsBaseline medicationsSwitching medicationsTreatment discontinuationMedication regimensPrimary outcomeMedication effectivenessAntipsychotic medicationAntipsychotic TrialsMedicationsAntipsychoticsClinical situationsOlanzapinePatientsRisperidoneIntervention effectivenessDearth of informationDiscontinuationRandom assignment
2005
Poor mental health and smoking: interactive impact on wages.
Jofre-Bonet M, Busch SH, Falba TA, Sindelar JL. Poor mental health and smoking: interactive impact on wages. The Journal Of Mental Health Policy And Economics 2005, 8: 193-203. PMID: 16385145.Peer-Reviewed Original ResearchConceptsPoor mental healthMental health problemsMental healthSmoking statusHealth problemsMental health disordersMental health statusGreater productivity lossCommunity Tracking SurveyMental health variesCurrent smokingFormer smokersSmokingHealth disordersHealth statusHealth variesDetermination of causalityWomenPositive associationPrimary aimHealthMalesProductivity lossStatusOutcomesIf smoking increases absences, does quitting reduce them?
Sindelar JL, Duchovny N, Falba TA, Busch SH. If smoking increases absences, does quitting reduce them? Tobacco Control 2005, 14: 99. PMID: 15791019, PMCID: PMC1747999, DOI: 10.1136/tc.2003.005884.Peer-Reviewed Original ResearchThe role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment
Dodge R, Sindelar J, Sinha R. The role of depression symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal Of Substance Use And Addiction Treatment 2005, 28: 189-196. PMID: 15780549, DOI: 10.1016/j.jsat.2004.12.005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmbulatory CareComorbidityConnecticutCross-Sectional StudiesDepressionFemaleFinancing, GovernmentHumansMaleMiddle AgedMotivationPatient CompliancePatient DischargePublic AssistanceRegression AnalysisSecondary PreventionSocioeconomic FactorsSubstance Abuse DetectionSubstance-Related DisordersTreatment OutcomeConceptsLength of staySubstance abuse treatment outcomesOutpatient substance abuse treatmentSubstance abuse treatmentDepressive symptomsInsurance statusTreatment outcomesAbstinence statusDepression symptomsDrug useDrug abstinenceAbuse treatmentReal-world clinical settingHigher depressive symptom scoresOutpatient substance abuse treatment programsDepressive symptom scoresSubstance abuse treatment programsSymptom scoresTreatment characteristicsPrimary drugDecreased likelihoodReferral sourceClinical settingSymptomsTreatment program
2004
Burning a hole in the budget
Busch SH, Jofre-Bonet M, Falba TA, Sindelar JL. Burning a hole in the budget. Applied Health Economics And Health Policy 2004, 3: 263-272. PMID: 15901200, DOI: 10.2165/00148365-200403040-00009.Peer-Reviewed Original ResearchConceptsDemand systemConsumer Expenditure Survey dataConsumer demand systemsMain expenditure categoriesExpenditure Survey dataState cigarette pricesPrice of cigarettesCigarette expenditurePrice dataHousehold expenditureExpenditure categoriesCigarette pricesExpensive habitsObservable heterogeneityHousehold membersExpenditureSocioeconomic variablesSurvey dataSmoking householdsHouseholdsPricesYears 1995GoodsHousingPattern of substitutionValue to smokers of improved cessation products: Evidence from a willingness-to-pay survey
Busch S, Falba T, Duchovny N, Jofre-Bonet M, O'Malley S, Sindelar J. Value to smokers of improved cessation products: Evidence from a willingness-to-pay survey. Nicotine & Tobacco Research 2004, 6: 631-639. PMID: 15370159, DOI: 10.1080/14622200410001727885.Peer-Reviewed Original ResearchConceptsSmoking cessation productsSmoking cessationCessation productsCessation treatmentEffective smoking cessation treatmentsWeight gainTobacco cessation treatmentSmoking cessation treatmentPresent studyClinical trialsEffective treatmentBaseline surveyCessationTreatmentNew HavenMedicationsSmokersTrialsCost effectiveness of disulfiram Treating cocaine use in methadone-maintained patients
Jofre-Bonet M, Sindelar JL, Petrakis IL, Nich C, Frankforter T, Rounsaville BJ, Carroll KM. Cost effectiveness of disulfiram Treating cocaine use in methadone-maintained patients. Journal Of Substance Use And Addiction Treatment 2004, 26: 225-232. PMID: 15063917, PMCID: PMC3662046, DOI: 10.1016/s0740-5472(04)00004-2.Peer-Reviewed Original ResearchConceptsMethadone treatmentClinical trialsCocaine useDouble-blind clinical trialCocaine dependenceStandard methadone treatmentBlind clinical trialMethadone-maintained patientsRandomized clinical trialsOpioid-dependent subjectsMethadone-maintained opiate addictsStandard treatmentOutcome measuresOpioid addictsPromising treatmentOpiate addictsIncremental costDisulfiramAdditional treatmentNumber of daysTrialsTreatmentCost effectivenessEconomic evaluationAddictsCost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes
Sindelar JL, Jofre-Bonet M, French MT, McLellan AT. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug And Alcohol Dependence 2004, 73: 41-50. PMID: 14687958, DOI: 10.1016/j.drugalcdep.2003.09.002.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismAmbulatory CareCase ManagementData CollectionData Interpretation, StatisticalFemaleFinancing, GovernmentFollow-Up StudiesHumansIllicit DrugsMaleOutcome and Process Assessment, Health CarePhiladelphiaPrepaid Health PlansRehabilitationRehabilitation, VocationalReproducibility of ResultsSocial AdjustmentSocial WorkSubstance-Related DisordersUrban Health ServicesConceptsCost-effectiveness analysisDrug Abuse Treatment Cost Analysis ProgramCost-benefit analysisCost-effectiveness ratioEmpirical examplePolicy inferencesEconomic analysisEconomic evaluationConflicting implicationsCost dataPaper identifiesMethodological principlesVariety of outcomesMultiple outcomesRange of outcomesSingle outcomeDifferent outcomesEmploymentAppropriate approachImplicationsParadox